HR 4439
116th Congress
House
Health
Child health
Drug safety, medical device, and laboratory regulation
Health programs administration and funding
Health promotion and preventive care
Infectious and parasitic diseases
Creating Hope Reauthorization Act
Introduced: September 20, 2019
See on congress.gov
Everywhere this bill has been
15 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 30, 2020
Received in the Senate.
Sep 29, 2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Sep 29, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 4439.
Sep 29, 2020
Considered under suspension of the rules. (consideration: CR H5023-5025)
Sep 29, 2020
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Sep 29, 2020
Placed on the Union Calendar, Calendar No. 451.
Sep 29, 2020
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-551.
Sep 29, 2020
The title of the measure was amended. Agreed to without objection.
Sep 29, 2020
Motion to reconsider laid on the table Agreed to without objection.
Sep 29, 2020
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5023)
Sep 9, 2020
Ordered to be Reported (Amended) by Voice Vote.
Sep 9, 2020
Committee Consideration and Mark-up Session Held.
Sep 23, 2019
Referred to the Subcommittee on Health.
Sep 20, 2019
Introduced in House
Sep 20, 2019
Referred to the House Committee on Energy and Commerce.
Plain-English summary
Creating Hope Reauthorization Act
This bill reauthorizes a Food and Drug Administration (FDA) program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)
Specifically, the bill reauthorizes the program through FY2024, but the FDA may award a voucher afterwards in certain instances.
What's happening now
Received in the Senate.
Committees of jurisdiction
2